Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Vater

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Occupational and Environmental Hygiene|August 19, 2020
Emissions associated with operations of four different additive manufacturing or 3D printing technologiesRachel E Zisook, Brooke D Simmons, Mark Vater, et al.
Research Square|May 25, 2026
QuTILs: Open-Source Image-Based Infiltrating Immune Cell Detection for Research ApplicationMark Vater, Roberto Salgado, Elijah Blige, et al.
NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.
Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Occupational and Environmental Hygiene|August 19, 2020
Emissions associated with operations of four different additive manufacturing or 3D printing technologiesRachel E Zisook, Brooke D Simmons, Mark Vater, et al.
Research Square|May 25, 2026
QuTILs: Open-Source Image-Based Infiltrating Immune Cell Detection for Research ApplicationMark Vater, Roberto Salgado, Elijah Blige, et al.
NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.
Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Pageof 1